Literature DB >> 33326909

Use and outcomes of prothrombin complex concentrate for factor Xa inhibitor-associated bleeding.

Annabel K Frank1, Previn Ganesan2, Ashley Thompson3, Margaret C Fang4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33326909      PMCID： PMC7867603          DOI： 10.1016/j.thromres.2020.11.037

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  10 in total

1.  Assessment of effectiveness of major bleeding management: proposed definitions for effective hemostasis: communication from the SSC of the ISTH.

Authors:  N Khorsand; A Majeed; R Sarode; J Beyer-Westendorf; S Schulman; K Meijer
Journal:  J Thromb Haemost       Date:  2015-10-27       Impact factor: 5.824

2.  Safety, efficacy, and cost of four-factor prothrombin complex concentrate (4F-PCC) in patients with factor Xa inhibitor-related bleeding: a retrospective study.

Authors:  Melanie N Smith; Lindsay Deloney; Cassandra Carter; Kyle A Weant; Evert A Eriksson
Journal:  J Thromb Thrombolysis       Date:  2019-08       Impact factor: 2.300

3.  Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors.

Authors:  Stuart J Connolly; Mark Crowther; John W Eikelboom; C Michael Gibson; John T Curnutte; John H Lawrence; Patrick Yue; Michele D Bronson; Genmin Lu; Pamela B Conley; Peter Verhamme; Jeannot Schmidt; Saskia Middeldorp; Alexander T Cohen; Jan Beyer-Westendorf; Pierre Albaladejo; Jose Lopez-Sendon; Andrew M Demchuk; Daniel J Pallin; Mauricio Concha; Shelly Goodman; Janet Leeds; Sonia Souza; Deborah M Siegal; Elena Zotova; Brandi Meeks; Sadia Ahmad; Juliet Nakamya; Truman J Milling
Journal:  N Engl J Med       Date:  2019-02-07       Impact factor: 91.245

4.  Specific Antidotes for Direct Oral Anticoagulant Reversal: Case Closed or Cold Case?

Authors:  Anne Godier; Anne-Céline Martin
Journal:  Circulation       Date:  2019-10-28       Impact factor: 29.690

5.  Apixaban and dalteparin in active malignancy-associated venous thromboembolism: The ADAM VTE trial.

Authors:  Robert D McBane; Waldemar E Wysokinski; Jennifer G Le-Rademacher; Tyler Zemla; Aneel Ashrani; Alfonso Tafur; Usha Perepu; Daniel Anderson; Krishna Gundabolu; Charles Kuzma; Juliana Perez Botero; Roberto A Leon Ferre; Stanislav Henkin; Charles J Lenz; Damon E Houghton; Prakash Vishnu; Charles L Loprinzi
Journal:  J Thromb Haemost       Date:  2019-11-28       Impact factor: 5.824

6.  Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients.

Authors:  S Schulman; C Kearon
Journal:  J Thromb Haemost       Date:  2005-04       Impact factor: 5.824

Review 7.  Management of direct factor Xa inhibitor-related major bleeding with prothrombin complex concentrate: a meta-analysis.

Authors:  Siavash Piran; Rasha Khatib; Sam Schulman; Ammar Majeed; Anne Holbrook; Daniel M Witt; Wojtek Wiercioch; Holger J Schünemann; Robby Nieuwlaat
Journal:  Blood Adv       Date:  2019-01-22

8.  Benefits and Harms of Oral Anticoagulant Therapy in Chronic Kidney Disease: A Systematic Review and Meta-analysis.

Authors:  Jeffrey T Ha; Brendon L Neuen; Lap P Cheng; Min Jun; Tadashi Toyama; Martin P Gallagher; Meg J Jardine; Manish M Sood; Amit X Garg; Suetonia C Palmer; Patrick B Mark; David C Wheeler; Vivekanand Jha; Ben Freedman; David W Johnson; Vlado Perkovic; Sunil V Badve
Journal:  Ann Intern Med       Date:  2019-07-16       Impact factor: 25.391

9.  Treatment of adults with intracranial hemorrhage on apixaban or rivaroxaban with prothrombin complex concentrate products.

Authors:  Renee Castillo; Alissa Chan; Steven Atallah; Katrina Derry; Mark Baje; Lara L Zimmermann; Ryan Martin; Leonid Groysman; Sara Stern-Nezer; Anush Minokadeh; Alan Nova; WanTing Huang; William Cang; Kendra Schomer
Journal:  J Thromb Thrombolysis       Date:  2021-01       Impact factor: 2.300

10.  Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer.

Authors:  Giancarlo Agnelli; Cecilia Becattini; Guy Meyer; Andres Muñoz; Menno V Huisman; Jean M Connors; Alexander Cohen; Rupert Bauersachs; Benjamin Brenner; Adam Torbicki; Maria R Sueiro; Catherine Lambert; Gualberto Gussoni; Mauro Campanini; Andrea Fontanella; Giorgio Vescovo; Melina Verso
Journal:  N Engl J Med       Date:  2020-03-29       Impact factor: 91.245
  10 in total
  1 in total

Review 1.  Perioperative Antithrombotic Management During Gastroenterological Surgery in Patients With Thromboembolic Risks: Current Status and Future Prospects.

Authors:  Takahisa Fujikawa
Journal:  Cureus       Date:  2022-03-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.